EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL

被引：1
|
作者：
Ruperto, N. [1 ]
Foeldvari, I. [2 ]
Alexeeva, E. [3 ]
Ayaz, N. Aktay [4 ]
Schulert, G. [5 ]
Ozen, S. [6 ]
Popov, A. [7 ]
Ramanan, A. [8 ]
Scott, C. [9 ]
Sozeri, B. [10 ]
Zholobova, E. [11 ]
Chakraborty, S. [12 ]
Zhu, X. [13 ]
Martin, R. [14 ]
Whelan, S.
Kaur, S. [15 ]
Pricop, L. [13 ]
Lovell, D. J. [5 ]
Martini, A. [16 ]
Brunner, H. [5 ]
机构：
[1] IRCCS Ist Giannina Gaslini, UOSID Ctr Trial, Genoa, Italy
[2] Hamburger Zentrum fuer Kinder & Jugendrheumatol, Rheumatol, Hamburg, Germany
[3] Natl Sci & Pract Ctr Childrens Hlth, Rheumatol, Moscow, Russia
[4] Istanbul Univ Cerrahpasa, Pediat Rheumatol, Fac Med, Istanbul, Turkiye
[5] Univ Cincinnati, Cincinnati Childrens Hosp, UC Dept Pediat, Cincinnati, OH USA
[6] Hacettepe Univ, Rheumatol, Med Fac, Ankara, Turkiye
[7] Ural State Med Univ Ekaterinburg, Rheumatol, Ekaterinburg, Russia
[8] Univ Bristol, Bristol Royal Hosp Children & Translat Hlth Sci, Bristol, Avon, England
[9] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Rheumatol, Cape Town, South Africa
[10] Univ Hlth Sci, Umraniye Training & Res Hosp, Div Pediat Rheumatol, Istanbul, Turkiye
[11] First Moscow State Med Univ, Moscow, Russia
[12] IQVIA, Durrham, NC USA
[13] Novartis Pharmaceut, E Hanover, NJ USA
[14] Novartis Ireland Ltd, Immunol, Dublin, Ireland
[15] Novartis Pharma AG, Immunol, Basel, Switzerland
[16] Univ Genoa, Rheumatol, Genoa, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
bDMARD; Clinical Trials;
D O I：
10.1136/annrheumdis-2023-eular.3679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0278
引用
收藏
页码：379 / 380
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.
    Brunner, Hermine
    Ruperto, Nicolino
    Zuber, Zbigniew
    Keane, Caroline
    Harari, Olivier
    Kenwright, Andrew
    Cuttica, Ruben J.
    Keltsev, Vladimir
    Xavier, Ricardo
    Penades, Inmaculada Calvo
    Nikishina, Irina
    Rubio-Perez, Nadina
    Alekseeva, Ekaterina
    Chasnyk, Vyacheslav
    Chavez, Jose
    Horneff, Gerd
    Opoka-Winiarska, Violetta
    Quartier, Pierre
    Silva, Clovis A.
    Silverman, Earl D.
    Spindler, Alberto
    Lovell, D. J.
    Martini, Alberto
    De Benedetti, Fabrizio
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S682 - S682
  • [22] SAFETY AND EFFICACY OF UPADACITINIB FOR PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, PHASE 1 TRIAL
    Brunner, H.
    Horneff, G.
    Foeldvari, I.
    Anton, J.
    Mohamed, M. E.
    Qian, Y.
    Unnebrink, K.
    Hao, S.
    Camp, H.
    Khan, N.
    Shmagel, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 108 - 109
  • [23] Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis
    Wallace, Carol A.
    Ringold, Sarah
    Bohnsack, John
    Spalding, Steven J.
    Brunner, Hermine I.
    Milojevic, Diana
    Schanberg, Laura E.
    Higgins, Gloria C.
    O'Neil, Kathleen M.
    Gottlieb, Beth S.
    Hsu, Joyce
    Punaro, Marilynn G.
    Kimura, Yukiko
    Hendrickson, Audrey
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (12) : 2459 - 2465
  • [24] One Year Efficacy and Safety Results of a Phase II Trial of Secukinumab in Patients with Rheumatoid Arthritis.
    Genovese, Mark C.
    Durez, Patrick
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Ligozio, Gregory
    Mpofu, Shephard
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S149 - S150
  • [25] Efficacy and Safety of Methotrexate in Oligoarticular Persistent Juvenile Idiopathic Arthritis
    Schmeling, Heinrike
    Foeldvari, Ivan
    Horneff, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S59 - S59
  • [26] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [27] Efficacy and safety of adalimumab in children with juvenile idiopathic arthritis (JIA)
    Lovell, DJ
    Ruperto, N
    Goodman, S
    Reiff, A
    Martini, A
    Giannini, EH
    Carcereri-De-Prati, R
    Spencer-Green, GT
    RHEUMATOLOGY, 2005, 44 : I25 - I26
  • [28] Safety and efficacy of influenza vaccination in children with juvenile idiopathic arthritis
    Toplak, Natasa
    Subelj, Vesna
    Kveder, Tanja
    Cucnik, Sasa
    Prosenc, Katarina
    Trampus-Bakija, Alenka
    Avcin, Tadej
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 404 - 405
  • [29] Safety and efficacy of meningococcal C vaccination in juvenile idiopathic arthritis
    Zonneveld-Huijssoon, Evelien
    Ronaghy, Arash
    van Rossum, Marion A. J.
    Rijkers, Ger T.
    van der Klis, Fiona R. M.
    Sanders, Elisabeth A. M.
    Vermeer-de Bondt, Patricia E.
    Hoes, Arno W.
    van der Net, Jan Jaap
    Engels, Carla
    Kuis, Wietse
    Prakken, Berent J.
    van Tol, Maarten J. D.
    Wulffraat, Nico M.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (02): : 639 - 646
  • [30] Safety and efficacy Tocilizumab therapy in children with juvenile idiopathic arthritis
    Alexeeva, Ekaterina
    Denisova, Rina
    Bzarova, Tatyana
    Valiyeva, Saniya
    Isayeva, Kseniya
    Lisitsyn, Alexander
    Tatyana, Sleptsova
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 386 - 386
12345